Page 37 - Biontech Se News Today : Breaking News, Live Updates & Top Stories | Vimarsana

BioNTech and Regeneron plan to jointly conduct clinical trials evaluating FixVac candidate BNT116 in combination with Libtayo for the treatment of advanced...

Market analysts are debating what future Covid vaccine demand will look when Covid becomes an endemic, seasonal virus.

Two doses of the Pfizer Inc and BioNTech SE COVID-19 vaccine was protective against severe disease in children aged 5 to 11 during the recent Omicron variant surge, but quickly lost most of its ability to prevent infection in the age group, according to a study by New York State researchers. The vaccine's efficacy against infection among those children declined to 12% at the end of January from 68% in mid-December compared to kids who did not get vaccinated, according the study https://www.medrxiv.org/content/10.1101/2022.02.25.22271454v1, which has not yet been peer reviewed.

Indonesia hit a daily record high of more than 64,000 cases last week, superseding daily infections in the previous wave which peaked just under 57,000 in July.

Indonesia hit a daily record high of more than 64,000 cases last week, superseding daily infections in the previous wave which peaked just under 57,000 in July.